Applicator
Latest Pfizer Inc. Patents:
- CDCP1 antibodies and antibody drug conjugates
- Pyrrolo[2,3-d]pyrimidinyl, Pyrrolo[2,3-b]pyrazinyl and Pyrrolo[2,3-d]pyridinyl Acryla-mides
- CRYSTAL-FREE HIGH-CONCENTRATION TESTOSTERONE CYPIONATE FORMULATIONS
- Dosing Regimen of Avelumab for the Treatment of Cancer
- 3-indol substituted derivatives, pharmaceutical compositions and methods for use
Description
FIG. 1 is front elevational view of an applicator showing my new design, the rear elevational view being identical;
FIG. 2 is a right side elevational view thereof, the left side elevational view being identical;
FIG. 3 is a top plan view thereof,
FIG. 4 is a bottom plan view thereof;
FIG. 5 is a front elevational view of the applicator showing my new design with the closure cap removed, the rear elevational view being identical;
FIG. 6 is a top plan view thereof;
FIG. 7 is a right side elevational view thereof; the left side elevational view being identical; and,
FIG. 8 is a bottom plan view of the closure cap shown in FIGS. 1-4.
Claims
A design for an applicator, shown and described.
Referenced Cited
U.S. Patent Documents
| D188397 | July 1960 | Hulsh |
| D290526 | June 23, 1987 | Vallis |
| D307191 | April 10, 1990 | Blutenthal |
| D377978 | February 11, 1997 | Haber et al. |
| D403076 | December 22, 1998 | York |
| D428142 | July 11, 2000 | Stromblad |
| D430703 | September 5, 2000 | Leslie et al. |
| D432714 | October 24, 2000 | Leslie et al. |
| 744718 | November 1903 | Cassidy |
| 1595327 | August 1926 | VanSant |
| 1947042 | February 1934 | Glennan |
| 4846159 | July 11, 1989 | Anzai et al. |
| 5131384 | July 21, 1992 | Obagi |
| 5871020 | February 16, 1999 | DeVone |
Patent History
Patent number: D450153
Type: Grant
Filed: Feb 28, 2001
Date of Patent: Nov 6, 2001
Assignee: Pfizer Inc. (NY, NY)
Inventor: Paul Knieriemen (New York, NY)
Primary Examiner: Paula A. Mortimer
Attorney, Agent or Law Firm: Evan J. Federman
Application Number: 29/137,849
Type: Grant
Filed: Feb 28, 2001
Date of Patent: Nov 6, 2001
Assignee: Pfizer Inc. (NY, NY)
Inventor: Paul Knieriemen (New York, NY)
Primary Examiner: Paula A. Mortimer
Attorney, Agent or Law Firm: Evan J. Federman
Application Number: 29/137,849
Classifications